Skip to main content

Table 1 Baseline Demographics of Patients with Idiopathic Pulmonary Fibrosis

From: Idiopathic pulmonary fibrosis in the United States: time to diagnosis and treatment

 

Treated with antifibrotics

before coded IPF diagnosis (N = 1,205)

Treated with antifibrotics after coded IPF diagnosis (N = 3,444)

Untreated (N = 40,242)

Total

(N = 44,891)

p value

Age

    

< 0.0001

 Mean (SD)

77.4 (4.9)

76.9 (4.7)

79.0 (5.5)

78.8 (5.4)

 

 Median

77.0

77.0

80.0

80.0

 

Age Group

    

< 0.001

 Less than 65

14 (1.9)

35 (4.8)

676 (93.2)

725 (1.6)

 

 65–74

320 (3.5)

1,071 (11.6)

7,824 (84.9)

9,215 (20.5)

 

 75–84

794 (2.7)

2,212 (7.6)

26,288 (89.7)

29,294 (65.3)

 

 Over 85

77 (1.4)

126 (2.2)

5,454 (96.4)

5,657 (12.6)

 

Gender

    

< 0.001

 Female

472 (2.1)

1,257 (5.5)

21,046 (92.4)

22,775 (50.7)

 

 Male

733 (3.3)

2,187 (9.9)

19,196 (86.8)

22,116 (49.3)

 

Race/Ethnicity

    

0.0039

 White

1,139 (2.7)

3,248 (7.8)

37,274 (89.5)

41,661 (92.8)

 

 Hispanic

30 (2.3)

85 (6.6)

1,175 (91.1)

1,290 (2.9)

 

 Black

14 (1.6)

44 (4.9)

833 (93.5)

891 (2.0)

 

 Other

22 (2.1)

67 (6.4)

960 (91.5)

1,049 (2.3)

 

Census Region

    

< 0.001

 Midwest

311 (2.8)

857 (7.7)

9,999 (89.5)

11,167 (24.9)

 

 Northeast

186 (2.6)

511 (7.0)

6,597 (90.4)

7,294 (16.2)

 

 South

525 (2.8)

1,555 (8.3)

16,571 (88.8)

18,651 (41.5)

 

 West

181 (2.4)

520 (6.8)

6,948 (90.8)

7,649 (17.0)

 

History of Tobacco Use

772 (64.1)

1,975 (57.3)

22,657 (56.3)

25,404 (56.6)

< 0.001